medigraphic.com
ISSN 2992-8036 (Electronic)
ISSN 2306-4102 (Print)
Órgano Oficial del Colegio Mexicano de Ortopedia y Traumatología

2004, Number 4

<< Back Next >>

Acta Ortop Mex 2004; 18 (4)

Usefulness of the cementation with vancomycin in hip arthroplasty with deep infection in one stage surgery

Alegre-Rico F, Campa AJL, Meza-Reyes G

Language: Spanish
References: 37
Page: 134-139
PDF size: 54.24 Kb.


ABSTRACT

Introduction. The total hip arthroplasty, is a surgical procedure that is useful to relieve pain, to improve movement in patients with coxarthrosis, and to resolve 31B and 31C (AO/ASIF) fractures. The infection in this patients it’s a fulminant complication. The treatment in the THR (total hip replacement) infection goes from local/systemic antibiotic therapy, wound irrigation, deep irrigation, antibiotic loaded chains of cement, one or two stage exchange with antibiotic impregnated cement, thru Girdlestone arthroplasty. Methods. 20 patients expedients were analyzed, who was performed primary THR Surgery that went thru infection, and received a surgical treatment at one stage exchange with vancomycin impregnated cement, 3 patients couldn’t be able to get the files, and 1 discharged from de Hospital by himself. A close statistically relation exist comparing the one stage arthroplasty with the date of the last outpatient service visit, and the infection eradication. With 0.683 and P > 0.07. Conclusions. The one stage surgery with vancomycin impregnated cement it’s an effective procedure to eradicate the infection in 14 patients (70%) of the 20 patients studied with deep infection after primary TH.


REFERENCES

  1. Abendschein W: Salvage of Infected Total Hip Replacement: Use of Antibiotic/ PMMA Spacer. Orthopaedics 1992; 15(2): 228-9.

  2. Alfaro-Adricin J, Gill HS, Murray DW: Cement Migration after THR. A comparison of chanley elite and eveter femoral etems using RSA. J Bone Joint Surg (Br) 1999; 81(1):30-4.

  3. Aspenberg P, Herbertsson P: Periprosthetic bone resorption. Particles versus movement. J Bone Joint Surg (Br) 1996; 78(4): 641-6.

  4. Barrack RL, Harris WH: The value of aspiration of the hip joint before revision total hip arthroplasty. J Bone Joint Surg 1993; 75(1): 66-76.

  5. Benjamin JB, Gie GA, Lee AJ, Ling RS, Volz RG: Cementing technique and effects of bleeding. J Bone Joint Surg (Br) 1987; 69(4): 620-4.

  6. Buchholz HW, Elson RA, Engelbretch E, Lodenkämper H, Röttger J, Siegel A: Management of deep infection of total hip replacement. J Bone Joint Surg (Br) 1981; 63-B(3): 342-53.

  7. Buchholz HW, Elson RA, Heinert K: Antibiotic-loaded acrylic cement: current concepts. Clin Orthop 1984; (190): 96-109.

  8. Calhoun JH, Mader JT: Treatment of Osteomyelitis with a biogradable antibiotic implant. Clin Orthop 1997; (341): 206-214.

  9. Callaghan JJ, Katz RP, Johnston RC: One Stage Revision Surgery of the Infected Hip. A minimum 10-year follo-wup study. Clin Orthop 1999; (369): 139-43.

  10. Carlsson AS, Josefsson G, Lindberg L: Revision with gentamicin impregnated cement for deep infections in total hip arthroplasties. J Bone Joint Surg Am 1978; 60(8): 1059-64.

  11. Cervantes I, Alegre F: Infección en la artroplastía total de cadera primaria. Tesis UNAM. Hospital de Traumatología y Ortopedia “Lomas Verdes” IMSS. México 2002.

  12. Coventry MB: Treatment of infections occurring in total hip surgery. Orthop Clin North Am 1975; 6(4): 991-1003.

  13. Chimento GF, Finger S, Barrack RL: Gram stain detection of infection during revision arthroplast. J Bone Joint Surg 1996; 78(5): 838-839.

  14. Garvin KL, Hanssen AD: Infection After Total Hip Arthroplasty. Post, present, and future. J Bone Joint Surg 1995; 77(10): 1576-88.

  15. Gristina H, Costerton J: Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis. J Bone Joint Surg 1985; 67(2): 264-273.

  16. Hanssen A, Rand A: Evaluation and treatment of infection at the site of a total hip or knee Arthroplasty. J Bone Joint Surg 1998; 80-A(6): 910-22.

  17. Hendrikcs J, van Horn J, van der Mei H, Busscher H: Backrounds of antibiotic loaded bone cement and prosthesis –related infection. Chapter 1. Biomaterials 2003.

  18. Hill C, Flamant R, Mazas F, Evrard J: Prophylactic cefazolin versus placebo in total hip replacement: Report of a multicentre double-blind randomized trial. Lancet 1981; 1(8224): 795-796.

  19. Johnson JA, Christie MJ, Sandler MP, Parks PFJr, Homra L, Kaye JJ: Detection of occult infection following total joint arthroplasty using sequential technetium 99m HDP bone scintigraphy and indium 111 WBC imaging. J Nucl Med 1988; 29(8): 1347-1353.

  20. Katz JN, Losina E, Barrett J, Phillips CB, Mahomed NN, Lew RA, et al: Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the United States medicare population. J Bone Joint Surg 2001; 83-A(11): 1622-1629.

  21. Kloos WE, Bannerman TL: Update on clinical significance of coagulase-negative staphylococci. Clin Microbiol Rev 1994; 7(1): 117-140.

  22. Lonner JH, Desai P, Dicesare PE, Steiner G, Zuckerman J: The releability of analysis of intraoperative frozen sections for identifying active infection during revision hip or knee arthroplasty. J Bone Jont Surg 1996; 78(10): 1553-58.

  23. Mauerhan DR, Nelson CL, Smith DL, Fitzgerald RH Jr, Slama TG, Petty RW, Jones RE, Evans RP: Prophylaxis against infection in total joint arthroplasty: One day of cefuroxime compared with three day of cefazolin. J Bone Joint Surg 1994; 76(1): 39-45.

  24. McDonald DJ, Fitzgerald RH, Ilstrup DM: Two-stage reconstruction of a total hip arthroplasty because of infection. J Bone Joint Surg 1989; 71(6): 828-834.

  25. Mirra JM, Amstutz HC, Matos M, Gold R: The pathology of the joint tissues and its clinical relevance in prosthesis failure. Clin Orthop 1976; (117): 221-240.

  26. Morrey BF: Instability after total hip arthroplasty. Orthop Clin North Am 1992; 23(2): 237-248.

  27. Neut D, van de Belt H, Stokroos I, van Horn J, van der Mei H, Busscher HJ: Biomaterial-associated infection of gentamicin loaded PMMA beads in orthopaedic revision surgery. J Antimicrob Chemother 2001; 47(6): 885-888.

  28. Pagnano MW, McLamb LA, Trousdale RT. Primary and revision total hip arthroplasty for patients 90 years of age and older. Mayo Clin Proc 2003; 78(3): 285-188.

  29. Paprosky W: Revision Total Hip arthroplasty. Monograph Series. American Academy of Orthopaedic Surgeons. Rosemont Illinois. 2001.

  30. Pring DJ, Henderson RG, Rivett AG, Krausz T, Coombs RR, Lavender JP: Autologous granulocyte scanning of painful prosthetic joints. J Bone Joint Surg 1986; 68(4): 647-652.

  31. Reing CM, Richin PF, Kenmore PI: Differential bone-scanning in the evaluation of a painful total joint replacement. J Bone Joint Surg 1979; 61(6A): 933-936.

  32. Robbins GM, Masri BA, Garbuz DS, Duncan CP: Primary total hip arthroplasty after infection. Inst Course Lect 2001; 50: 317-333.

  33. Salcedo J, Hernandez-Rosas C, Meza G. Uso de Cemento Medicado en prótesis de cadera infectada. (Reporte preliminar). Tesis UNAM. Hospital de Traumatología y Ortopedia “Lomas Verdes” IMSS. 1998.

  34. Spangehl MJ, Masri BA, O´Connell JX, Duncan CP: Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties. J Bone Joint Surg 1999; 81(5): 672-683.

  35. Sterling GJ, Crawford S, Potter JH, Koerbin G, Crawford R: The pharmacokinetics of Simplex-tobramycin bone cement. J Bone Joint Surg 2003; 85-B(5): 646-649.

  36. Trippel SB: Antibiotic-impregnated cement in total Joint arhroplasty. J Bone Joint Surg 1986; 68(8): 1297-1302.

  37. Wichelhaus TA, Dingeldein E, Rauschmann M, Kluge S, Dieterich R, Shäffer V, Brade V: Elution characteristics of vancomycin, teicoplanin, gentamicin and clindamycin from calcium sulphate beads. J Antimicrob Chemother 2001; 48(1): 117-119.




2020     |     www.medigraphic.com